Stay updated on KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A consolidated Locations section now lists North Carolina and South Carolina locations, replacing the prior North Carolina Locations and South Carolina Locations subsections. The footer now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link has been removed.
    Difference
    0.3%
    Check dated 2025-12-23T09:46:52.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Footer revision from v3.3.1 to v3.3.2; no changes to study details or trial data.
    Difference
    0.1%
    Check dated 2025-12-01T17:56:32.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.1. No changes were made to the study details or user-facing content.
    Difference
    0.1%
    Check dated 2025-11-24T15:02:58.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The government funding/operating status notice has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T07:17:39.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Results have been posted for the study, including primary and secondary outcomes (PFS, response rate, and overall survival) and related time frames. Updated study dates reflect the start date, primary completion date, and study completion date.
    Difference
    0.4%
    Check dated 2025-11-03T01:30:12.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T10:23:31.000Z thumbnail image

Stay in the know with updates to KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page.